register

News - MedTech & Diagnostics

How medtech is tackling the supply chain challenges: Cardinal Health MD

Health Industry Hub | August 1, 2022 |

MedTech News: COVID-19 has exposed the weaknesses in the global supply chain and most businesses are still grappling with disruptions two years later.

Jane Crowe, Managing Director ANZ, Cardinal Health joined Health Industry Hub to reflect on the evolution of the supply chain environment and where the greatest risks lie currently. She discussed the related inflation pressures impacting medtechs as companies operate in a highly competitive market.

Jane also shared her perspectives on the impact of the supply chain disruptions on patient care and how Cardinal Health is navigating hospital and clinician expectations on cost and inventory issues. There are key factors to be considered in shaping a supply chain ecosystem that is fit-for-purpose.

Lastly, the COVID-19 pandemic has been “a master class in leadership”. Jane discussed the greatest leadership lessons and how these traits should be learned and adopted by managers and the wider workforce.


News - Pharmaceuticals

The rare case for a reform agenda that changes the reflection - Rare Cancer Australia, From rare to recognised: the changing story of cancer

The ‘rare’ case for a reform agenda that changes the reflection

Health Industry Hub | September 8, 2026 |

A new policy reform agenda is calling for faster diagnosis, broader access to precision medicine and a national focus on […]

More


News - Pharmaceuticals

New petition takes aim at cutting the cost of cancer care - Leukaemia Foundation

New petition takes aim at cutting the cost of cancer care

Health Industry Hub | September 8, 2026 |

A new national scorecard has exposed major gaps in the assistance available to Australians who travel long distances and stay […]

More


News - MedTech & Diagnostics

National Lobbying Act to clean up politics - Dr Monique Ryan

National Lobbying Act to clean up politics

Health Industry Hub | September 8, 2026 |

Two thirds of registered lobbyists in Canberra have worked in state or federal government, exposing a revolving door through which […]

More


News - Pharmaceuticals

Interim funding agreed for new bleeding disorder therapies

Interim funding secured for new bleeding disorder therapies

Health Industry Hub | September 7, 2026 |

State and federal Health Ministers have agreed to interim funding arrangements for three new therapies for bleeding disorders, expanding access […]

More


This content is copyright protected. Please subscribe to gain access.